8-OH-DPAT as a 5-HT7 agonist: phase shifts of the circadian biological clock through increases in cAMP production.
paper
Cited
Public
Unavailable
- Authors
- Sprouse, Jeffrey; Reynolds, Linda; Li, Xingfang; Braselton, John; Schmidt, Anne
- Year
- 2004
- Journal
- Neuropharmacology
- PMID
- 14654097
- DOI
- 10.1016/j.neuropharm.2003.08.007
Neurons in the suprachiasmatic nucleus (SCN), the site of the endogenous biological clock in mammals, fire spontaneously, peaking in firing rate near ZT6 or at the midpoint of the light phase in a 12:12 light-dark cycle. In rat hypothalamic slices, tissue incubations with drugs can produce a shift in this daily rhythm, the magnitude of which is dependent upon dose and the time of treatment. Previous work with 8-OH-DPAT had noted its ability to produce a phase advance, an earlier occurrence of the peak in neuronal firing, when applied at ZT6. Activation of 5-HT7 receptors was thought to be responsible for the shift, despite the clear preference of 8-OH-DPAT for 5-HT1A sites in terms of receptor binding affinity. In the present work, the actions of 8-OH-DPAT in SCN slices were confirmed and expanded to include additional dose-response and antagonist treatments. By itself, 8-OH-DPAT produced a concentration-dependent phase advance that was sensitive to co-application with 5-HT7 antagonists (ritanserin, mesulergine, SB-269970), but not to 5-HT1A antagonists (WAY-100,635, UH-301). Assignment of the receptor mechanisms for the antagonists employed was accomplished in experiments measuring binding affinities and the generation of cAMP, the latter monitored in a HEK-293 cell line expressing the r5-HT7 receptor and in tissue derived from rat SCN. The results indicate that the increases observed in cAMP levels are small but appear to be sufficient to produce a pharmacological resetting of the clock pacemaker. By aiding in the identification of the 5-HT receptor subtype responsible for the observed phase shifts and cAMP changes, 8-OH-DPAT represents an important pharmacological tool for 5-HT7 receptor activation, essentially broadening its role as the prototypical 5-HT1A agonist to one combining these two receptor activities.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Genome-wide association study of theta band event-related oscillations identifies serotonin receptor gene HTR7 influencing risk of alcohol dependence. | 2011 | 21184583 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| The 5-HT1A receptor antagonist WAY-100635 maleate promotes retinal ganglion cell differentiation and protects the retino-visual circuits. | Dutta S et al. | β | 2026 | β |
| Circadian responses to non-photic treatments in BTBR mice. | Vijaya Shankara J et al. | β | 2025 | β |
| Molecular characterisation and developmental expression analysis of the <i>5-HT7</i> receptor in <i>Chrysopa formosa</i>. | Li F et al. | β | 2025 | β |
| Monoamine receptors targeted by methamphetamine differentially modulate basal and fentanyl-depressed respiration in mice. | Elder HJ et al. | β | 2025 | β |
| Role of chronotype in depression. | Zhao Y et al. | β | 2025 | β |
| Synthesis, Pharmacological Characterization, and Binding Mode Analysis of 8-Hydroxy-Tetrahydroisoquinolines as 5-HT<sub>7</sub> Receptor Inverse Agonists. | Chan CB et al. | β | 2025 | β |
| Acetyl-11-keto-beta boswellic acid(AKBA) modulates CSTC-pathway by activating SIRT-1/Nrf2-HO-1 signalling in experimental rat model of obsessive-compulsive disorder: Evidenced by CSF, blood plasma and histopathological alterations. | Sethi P et al. | β | 2023 | β |
| Development and challenges in the discovery of 5-HT<sub>1A</sub> and 5-HT<sub>7</sub> receptor ligands. | Singh D et al. | β | 2023 | β |
| Deletion of the Serotonin Receptor 7 Gene Changed the Development and Behavior of the Mosquito, <i>Aedes aegypti</i>. | Li M et al. | β | 2022 | β |
| Improvement of urethral dysfunction by 5-HT<sub>1A</sub> Β receptor agonist NLX-112 in diabetic rats. | Li M et al. | β | 2022 | β |
| Repeated lysergic acid diethylamide (LSD) reverses stress-induced anxiety-like behavior, cortical synaptogenesis deficits and serotonergic neurotransmission decline. | De Gregorio D et al. | β | 2022 | β |
| Translating biased agonists from molecules to medications: Serotonin 5-HT<sub>1A</sub> receptor functional selectivity for CNS disorders. | Newman-Tancredi A et al. | β | 2022 | β |
| Chronobiologic parameter changes in patients with major depressive disorder and sleep disturbance treated with adjunctive brexpiprazole: An open-label, flexible-dose, exploratory substudy. | Krystal AD et al. | β | 2021 | β |
| International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function. | Barnes NM et al. | β | 2021 | β |
| Medial PFC AMPA receptor and BDNF signaling are required for the rapid and sustained antidepressant-like effects of 5-HT<sub>1A</sub> receptor stimulation. | Fukumoto K et al. | β | 2020 | β |
| Potential Pathways for Circadian Dysfunction and Sundowning-Related Behavioral Aggression in Alzheimer's Disease and Related Dementias. | Todd WD | β | 2020 | β |
| Relationship between Auditory Evoked Potentials and Circadian Preference in Patients with Major Depressive Episodes. | Park YM | β | 2020 | β |
| Towards selective CNS PET imaging of the 5-HT<sub>7</sub> receptor system: Past, present and future. | L'Estrade ET et al. | β | 2020 | β |
| A Symphony of Signals: Intercellular and Intracellular Signaling Mechanisms Underlying Circadian Timekeeping in Mice and Flies. | Hegazi S et al. | β | 2019 | β |
| Biphasic effects of 5-HT<sub>1A</sub> agonism on impulsive responding are dissociable from effects on anxiety in the variable consecutive number task. | Groft ML et al. | β | 2019 | β |
| Circadian regulation of depression: A role for serotonin. | Daut RA et al. | β | 2019 | β |
| 5-HT1A receptor ligands and their therapeutic applications: review of new patents. | StaroΕ J et al. | β | 2018 | β |
| Electroacupuncture alleviates chemotherapy-induced pain through inhibiting phosphorylation of spinal CaMKII in rats. | Zhang Y et al. | β | 2018 | β |
| Role of 5-HT1A Receptor Stimulation in the Medial Prefrontal Cortex in the Sustained Antidepressant Effects of Ketamine. | Fukumoto K et al. | β | 2018 | β |
| Characterization of three serotonin receptors from the small white butterfly, Pieris rapae. | Qi YX et al. | β | 2017 | β |
| Roles of 5-HT<sub>1A</sub> receptor in the expression of AMPA receptor and BDNF in developing mouse cortical neurons. | Yoshimura Y et al. | β | 2017 | β |
| Selective serotonin 5-HT1A receptor biased agonists elicitdistinct brain activation patterns: a pharmacoMRI study. | Becker G et al. | β | 2016 | β |
| Synthesis and Structure-Activity Relationship Analysis of 5-HTβ Receptor Antagonists: Piperazin-1-yl Substituted Unfused Heterobiaryls. | Strekowski L et al. | β | 2016 | β |
| What Do We Really Know About 5-HT<sub>1A</sub> Receptor Signaling in Neuronal Cells? | Rojas PS et al. | β | 2016 | β |
| An Orally Active Phenylaminotetralin-Chemotype Serotonin 5-HT7 and 5-HT1A Receptor Partial Agonist that Corrects Motor Stereotypy in Mouse Models. | Canal CE et al. | β | 2015 | β |
| Differentiated effects of the multimodal antidepressant vortioxetine on sleep architecture: Part 2, pharmacological interactions in rodents suggest a role of serotonin-3 receptor antagonism. | Leiser SC et al. | β | 2015 | β |
| Involvement of 5-HTβ receptors in vortioxetine's modulation of circadian rhythms and episodic memory in rodents. | Westrich L et al. | β | 2015 | β |
| Persistent modification of forebrain networks and metabolism in rats following adolescent exposure to a 5-HT7 receptor agonist. | Canese R et al. | β | 2015 | β |
| Targeting the Serotonin 5-HT7 Receptor in the Search for Treatments for CNS Disorders: Rationale and Progress to Date. | Nikiforuk A | β | 2015 | β |
| Clozapine effects on adenylyl cyclase activity and serotonin type 1A receptors in human brain post-mortem. | Marazziti D et al. | β | 2014 | β |
| Distinct temporal expression of 5-HT(1A) and 5-HT(2A) receptors on cerebellar granule cells in mice. | Oostland M et al. | β | 2014 | β |
| Selective pharmacological blockade of the 5-HT7 receptor attenuates light and 8-OH-DPAT induced phase shifts of mouse circadian wheel running activity. | Shelton J et al. | β | 2014 | β |
| Serotonin 1A receptor inhibits the status epilepticus induced by lithium-pilocarpine in rats. | Yang Y et al. | β | 2014 | β |
| Serotonin and sensory nerves: meeting in the cardiovascular system. | Watts SW | β | 2014 | β |
| The 5-HT7 receptor as a potential target for treating drug and alcohol abuse. | Hauser SR et al. | β | 2014 | β |
| Animal models of the serotonin syndrome: a systematic review. | Haberzettl R et al. | β | 2013 | β |
| A role for peripheral 5-HT2 receptors in serotonin-induced facilitation of the expulsion phase of ejaculation in male rats. | Ishigami T et al. | β | 2013 | β |
| Autoradiographic evaluation of [3H]CUMI-101, a novel, selective 5-HT1AR ligand in human and baboon brain. | Kumar JS et al. | β | 2013 | β |
| Evidence for the involvement of 5-HT1A receptor in the acute antidepressant-like effect of creatine in mice. | Cunha MP et al. | β | 2013 | β |
| Hippocampal serotonin-1A receptor function in a mouse model of anxiety induced by long-term voluntary wheel running. | Fuss J et al. | β | 2013 | β |
| Neuronal control of pedal sole cilia in the pond snail Lymnaea stagnalis appressa. | Longley RD et al. | β | 2013 | β |
| Photic and nonphotic responses of the circadian clock in serotonin-deficient Pet-1 knockout mice. | Paulus EV et al. | β | 2013 | β |
| Sensitivity of hippocampal 5-HT1A receptors to mild stress in BDNF-deficient mice. | Burke TF et al. | β | 2013 | β |
| Systematic identification of proteins that elicit drug side effects. | Kuhn M et al. | β | 2013 | β |
| The effects of combining serotonin reuptake inhibition and 5-HT7 receptor blockade on circadian rhythm regulation in rodents. | Westrich L et al. | β | 2013 | β |
| Modulatory effects of two novel agonists for serotonin receptor 7 on emotion, motivation and circadian rhythm profiles in mice. | Adriani W et al. | β | 2012 | β |
| Serotonin and blood pressure regulation. | Watts SW et al. | β | 2012 | β |
| Stress- and antidepressant treatment-induced modifications of 5-HTβ receptor functions in the rat brain. | Tokarski K et al. | β | 2012 | β |
| Synthesis and configuration determination of all enantiopure stereoisomers of the melatonin receptor ligand 4-phenyl-2-propionamidotetralin using an expedient optical resolution of 4-phenyl-2-tetralone. | Lucarini S et al. | β | 2012 | β |
| Behavioral deficits and exaggerated feedback control over raphe-hippocampal serotonin neurotransmission in restrained rats. | Haleem DJ | β | 2011 | β |
| Entrainment of circadian clocks in mammals by arousal and food. | Mistlberger RE et al. | β | 2011 | β |
| Genome-wide association study of theta band event-related oscillations identifies serotonin receptor gene HTR7 influencing risk of alcohol dependence. | Zlojutro M et al. | β | 2011 | β |
| Role of the 5-HT7 receptor in the central nervous system: from current status to future perspectives. | Matthys A et al. | β | 2011 | β |
| Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders. | Leopoldo M et al. | β | 2011 | β |
| 5-HT(7) receptor modulators: a medicinal chemistry survey of recent patent literature (2004 - 2009). | Leopoldo M et al. | β | 2010 | β |
| Actions of the prototypical 5-HT1A receptor agonist 8-OH-DPAT at human alpha2-adrenoceptors: (+)8-OH-DPAT, but not (-)8-OH-DPAT is an alpha2B subtype preferential agonist. | Heusler P et al. | β | 2010 | β |
| Correction of respiratory disorders in a mouse model of Rett syndrome. | Abdala AP et al. | β | 2010 | β |
| Practical asymmetric synthesis of bioactive aminotetralins from a racemic precursor using a regiodivergent resolution. | Webster R et al. | β | 2010 | β |
| Adrenalectomy modifies the hippocampal 5-HT(1A) receptors and the anxiolytic-like effect of 8-OH-DPAT in rats. | Briones-Aranda A et al. | β | 2009 | β |
| Antagonism of 5-HT(1A) receptors uncovers an excitatory effect of SSRIs on 5-HT neuronal activity, an action probably mediated by 5-HT(7) receptors. | Bosker FJ et al. | β | 2009 | β |
| Chronic reductions in serotonin transporter function prevent 5-HT1B-induced behavioral effects in mice. | Shanahan NA et al. | β | 2009 | β |
| Expression and function of 5-HT7 receptors in smooth muscle preparations from equine duodenum, ileum, and pelvic flexure. | Prause AS et al. | β | 2009 | β |
| New light on the serotonergic paradox in the rat circadian system. | Cuesta M et al. | β | 2009 | β |
| Serotonergic and catecholaminergic interactions with co-localised dopamine-melatonin neurones in the hypothalamus of the female turkey. | Kang SW et al. | β | 2009 | β |
| Signal transduction and functional selectivity of F15599, a preferential post-synaptic 5-HT1A receptor agonist. | Newman-Tancredi A et al. | β | 2009 | β |
| The 5-HT7 receptor and disorders of the nervous system: an overview. | Hedlund PB | β | 2009 | β |
| 5-HT7 receptor stimulation by 8-OH-DPAT counteracts the impairing effect of 5-HT(1A) receptor stimulation on contextual learning in mice. | Eriksson TM et al. | β | 2008 | β |
| Acute ethanol modulates glutamatergic and serotonergic phase shifts of the mouse circadian clock in vitro. | Prosser RA et al. | β | 2008 | β |
| Altered photic and non-photic phase shifts in 5-HT(1A) receptor knockout mice. | Smith VM et al. | β | 2008 | β |
| Anxiolytics may promote locomotor function recovery in spinal cord injury patients. | Guertin PA | β | 2008 | β |
| Conservation of structure, signaling and pharmacology between two serotonin receptor subtypes from decapod crustaceans, Panulirus interruptus and Procambarus clarkii. | Spitzer N et al. | β | 2008 | β |
| Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands: structure-activity relationship elucidation. | Peters JU et al. | β | 2008 | β |
| Serotonergic activation potentiates light resetting of the main circadian clock and alters clock gene expression in a diurnal rodent. | Cuesta M et al. | β | 2008 | β |
| Serotonin modulates vocalizations and territorial behavior in an amphibian. | Ten Eyck GR | β | 2008 | β |
| Serotonin receptors. | Nichols DE et al. | β | 2008 | β |
| The effects of photic and nonphotic stimuli in the 5-HT7 receptor knockout mouse. | Gardani M et al. | β | 2008 | β |
| Activation of the external urethral sphincter central pattern generator by a 5-HT(1A) receptor agonist in rats with chronic spinal cord injury. | Dolber PC et al. | β | 2007 | β |
| Chronobiology in the endocrine system. | Haus E | β | 2007 | β |
| Differential profile of typical, atypical and third generation antipsychotics at human 5-HT7a receptors coupled to adenylyl cyclase: detection of agonist and inverse agonist properties. | Rauly-Lestienne I et al. | β | 2007 | β |
| Effect of 5-hydroxytryptamine1 serotonin receptor agonists on noxiously stimulated micturition in cats with chronic spinal cord injury. | Gu B et al. | β | 2007 | β |
| Electrophysiology of the suprachiasmatic circadian clock. | Brown TM et al. | β | 2007 | β |
| Structure of the human 5-HT7 receptor gene and characterization of its promoter region. | Laenen K et al. | β | 2007 | β |
| Am5-HT7: molecular and pharmacological characterization of the first serotonin receptor of the honeybee (Apis mellifera). | Schlenstedt J et al. | β | 2006 | β |
| Contribution of spinal 5-HT1A and 5-HT7 receptors to locomotor-like movement induced by 8-OH-DPAT in spinal cord-transected mice. | Landry ES et al. | β | 2006 | β |
| D5 dopamine receptor regulation of reactive oxygen species production, NADPH oxidase, and blood pressure. | Yang Z et al. | β | 2006 | β |
| Fluoxetine modulates the circadian biological clock via phase advances of suprachiasmatic nucleus neuronal firing. | Sprouse J et al. | β | 2006 | β |
| Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application. | Millan MJ | β | 2006 | β |
| Reanalysis of constitutively active rat and human 5-HT7(a) receptors in HEK-293F cells demonstrates lack of silent properties for reported neutral antagonists. | Romero G et al. | β | 2006 | β |
| Serotonergic mediation of constant light-potentiated nonphotic phase shifting of the circadian locomotor activity rhythm in Syrian hamsters. | Knoch ME et al. | β | 2006 | β |
| Serotonergic pre-treatments block in vitro serotonergic phase shifts of the mouse suprachiasmatic nucleus circadian clock. | Prosser RA et al. | β | 2006 | β |
| The circadian visual system, 2005. | Morin LP et al. | β | 2006 | β |
| 5-HT7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern. | Hedlund PB et al. | β | 2005 | β |
| A serotonin receptor antagonist induces oocyte maturation in both frogs and mice: evidence that the same G protein-coupled receptor is responsible for maintaining meiosis arrest in both species. | Sheng Y et al. | β | 2005 | β |
| Central 5-HT7 receptors are critical for reflex activation of cardiac vagal drive in anaesthetized rats. | Kellett DO et al. | β | 2005 | β |
| Circadian rhythm phenotype of 5-HT7 receptor knockout mice: 5-HT and 8-OH-DPAT-induced phase advances of SCN neuronal firing. | Sprouse J et al. | β | 2005 | β |
| Cyclic AMP mediates circadian phase shifts induced by microinjection of serotonergic drugs in the hamster dorsal raphe nucleus. | Duncan MJ et al. | β | 2005 | β |
| Effect of haloperidol on mPer1 gene expression in mouse suprachiasmatic nuclei. | Viyoch J et al. | β | 2005 | β |
| Short-term constant light potentiation of large-magnitude circadian phase shifts induced by 8-OH-DPAT: effects on serotonin receptors and gene expression in the hamster suprachiasmatic nucleus. | Duncan MJ et al. | β | 2005 | β |
| Differential inverse agonist efficacies of SB-258719, SB-258741 and SB-269970 at human recombinant serotonin 5-HT7 receptors. | MahΓ© C et al. | β | 2004 | β |
| Functions of 5-HT2A receptor and its antagonists in the cardiovascular system. | Nagatomo T et al. | β | 2004 | β |
| Mice lacking 5-HT receptors show specific impairments in contextual learning. | Roberts AJ et al. | β | 2004 | β |
| Pharmacological modulation of circadian rhythms: a new drug target in psychotherapeutics. | Sprouse J | β | 2004 | β |
| Serotonin-induced phase advances of SCN neuronal firing in vitro: a possible role for 5-HT5A receptors? | Sprouse J et al. | β | 2004 | β |
| Chronobiology of the endocrine system. | Nicolau GY et al. | β | 1989 | β |